Skip to main content

Pain, Postoperative

44
Pipeline Programs
30
Companies
50
Clinical Trials
2 recruiting
3
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
13
0
16
13
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 66 programs with unclassified modality

On Market (3)

Approved therapies currently available

Viatris
LYRICAApproved
pregabalin
Viatris
oral2010
72M Part D
Viatris
LYRICA CRApproved
pregabalin
Viatris
oral2017
402K Part D
Pfizer
BEXTRAApproved
valdecoxib
Pfizer
oral2001

Competitive Landscape

35 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
6 programs
4
2
Bupivacaine BlockPhase 41 trial
valdecoxibPhase 4Small Molecule1 trial
PMI-150Phase 31 trial
PregabalinPhase 3
celecoxib and ibuprofen SRPhase 3
+1 more programs
Active Trials
NCT00709436Completed250Est. Aug 2011
NCT00927888Completed56Est. Aug 2010
NCT00650598Completed328Est. Aug 2004
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
4 programs
2
Parecoxib sodiumPhase 41 trial
ropivacaine, fentanyl, adrenalinePhase 41 trial
pMDTN/A1 trial
pMDTN/A1 trial
Active Trials
NCT03759275Completed480Est. Aug 2021
NCT03761550Completed480Est. Aug 2021
NCT02272660Completed74Est. Aug 2015
+1 more trials
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
3 programs
2
Gabapentin 250mg/5mL NDC:59762-5025-01Phase 41 trial
Lidoderm 5 % Topical PatchPhase 41 trial
Medication Tracking FormN/A1 trial
Active Trials
NCT04349397Unknown100Est. Jun 2021
NCT01977937Completed55Est. Apr 2018
NCT03500211Completed50Est. Mar 2019
Lundbeck
LundbeckDenmark - Copenhagen
3 programs
2
ropivacaine 0.2%, 50 mLPhase 41 trial
ropivacaine and ketorolacPhase 41 trial
MobilizationN/A1 trial
Active Trials
NCT01018277Completed26Est. Jun 2010
NCT00927225Completed16Est. Jun 2009
NCT01344395Completed80Est. Sep 2011
Viatris
ViatrisCANONSBURG, PA
3 programs
3
1
PregabalinPhase 31 trial
celecoxib and ibuprofen SRPhase 31 trial
pregabalinPhase 31 trial
Active Trials
NCT00551135Completed425Est. Sep 2009
NCT00150280Completed132Est. Jul 2005
NCT00468845Completed501Est. Oct 2010
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
1
1
Abdominal wall block with liposomal bupivicainePhase 41 trial
Active ComparatorPhase 11 trial
Active Trials
NCT05247255Enrolling By Invitation80Est. Jan 2027
NCT03294109Completed146Est. Jun 2020
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
MethadonePhase 41 trial
Active Trials
NCT06576830Recruiting440Est. Jun 2029
Baxter International
4 programs
2
ParacetamolPhase 31 trial
ParacetamolPhase 31 trial
ParacetamolPHASE_3
ParacetamolPHASE_3
Active Trials
NCT00508495Completed148Est. Mar 2008
NCT00406679Completed135Est. Oct 2007
Vivozon
VivozonKorea - Gyeonggi
4 programs
1
3
VVZ-149 InjectionsPhase 31 trial
VVZ-149 InjectionsPhase 31 trial
VVZ-149 InjectionsPhase 31 trial
VVZ-149 InjectionsPhase 21 trial
Active Trials
NCT03997812Completed60Est. Aug 2019
NCT03997838Completed307Est. Aug 2019
NCT04430088Unknown300Est. Jan 2021
+1 more trials
Biocorp
3 programs
2
N1539Phase 31 trial
N1539Phase 31 trial
intraperitoneal washing with saline solutionN/A1 trial
Active Trials
NCT03290521Completed277Est. Dec 2020
NCT03434275Completed194Est. May 2019
NCT03323385Completed57Est. Sep 2018
Neumentum
NeumentumNJ - Summit
1 program
1
Ketorolac TromethaminePhase 31 trial
Active Trials
NCT05324358Suspended341Est. May 2027
BioQ Pharma
1 program
1
RopivacainePhase 31 trial
Active Trials
NCT02959476Completed132Est. Aug 2018
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
3 programs
3
MK0686Phase 2
MK0719Phase 2
MK2295Phase 2
MSD
MSDIreland - Ballydine
3 programs
3
MK0686Phase 21 trial
MK0719Phase 21 trial
MK2295Phase 21 trial
Active Trials
NCT00533403Completed114Est. Nov 2004
NCT00424424Terminated81Est. Jan 2007
NCT00387140Completed89Est. May 2007
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
2 programs
1
Oral Gabapentin and Intravenous AcetaminophenPhase 21 trial
Healing TouchN/A1 trial
Active Trials
NCT05053360Completed210Est. Apr 2023
NCT03679013Completed19Est. Jul 2019
Temple Therapeutics
1
Dexamethasone 4mgPhase 21 trial
Active Trials
NCT04919317Completed56Est. Nov 2020
Luye Pharma
Luye PharmaChina - Shanghai
1 program
1
LPM3480392 InjectionPhase 21 trial
Active Trials
NCT06204120Completed150Est. Jul 2023
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
1
Ropivacaine HCLPhase 21 trial
Active Trials
NCT03149783Unknown80Est. Oct 2021
Talphera
TalpheraCA - San Mateo
1 program
1
Sufentanil NanoTab PCA System/15 mcgPhase 21 trial
Active Trials
NCT00859313Completed30Est. Aug 2009
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
Topical Ocular BL1332 low dosePhase 21 trial
Active Trials
NCT07412496Completed130Est. Oct 2026
Lotus Pharmaceuticals
Lotus PharmaceuticalsTaiwan - Taipei
1 program
1
FX301Phase 11 trial
Active Trials
NCT04826328Completed85Est. Mar 2022
Eppendorf
3 programs
Open abdominal prostatectomyN/A1 trial
Opioid administrationN/A1 trial
Registry for Acute Pain TreatmentN/A1 trial
Active Trials
NCT03565705Completed636Est. Oct 2018
NCT03380949Completed96Est. Jun 2018
NCT02846610Terminated224,744Est. May 2023
Merck & Co.
Merck & Co.RAHWAY, NJ
3 programs
MK0686PHASE_2
MK0719PHASE_2
MK2295PHASE_2
AtriCure
1 program
Atricure's crysoSPHERE probeN/A1 trial
Active Trials
NCT06384664Recruiting80Est. Apr 2028
Masimo
MasimoIRVINE, CA
1 program
Bridge deviceN/A1 trial
Active Trials
NCT05017701Terminated5Est. May 2023
Nielsen BioSciences
Nielsen BioSciencesCA - San Diego
1 program
Local infiltration analgesiaN/A1 trial
Active Trials
NCT01362075Terminated74Est. Oct 2014
City Therapeutics
City TherapeuticsCAMBRIDGE, MA
1 program
NRS 0. hourN/A1 trial
Active Trials
NCT06566859Not Yet RecruitingEst. Feb 2025
Meissner
1 program
Prospective data collectionN/A
Sandoz
SandozAustria - Kundl
1 program
Prospective data collectionN/A
Combined Therapeutics
Sitz BathN/A1 trial
Active Trials
NCT05666648Unknown60Est. Jan 2023

+5 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Human BioSciencesMethadone
Oregon TherapeuticsLidoderm 5 % Topical Patch
Angeles TherapeuticsAbdominal wall block with liposomal bupivicaine
UNION therapeuticsParecoxib sodium
UNION therapeuticsropivacaine, fentanyl, adrenaline
Oregon TherapeuticsGabapentin 250mg/5mL NDC:59762-5025-01
Knight TherapeuticsBupivacaine
Lundbeckropivacaine and ketorolac
Lundbeckropivacaine 0.2%, 50 mL
PfizerBupivacaine Block
Pfizervaldecoxib
NeumentumKetorolac Tromethamine
VivozonVVZ-149 Injections
VivozonVVZ-149 Injections
VivozonVVZ-149 Injections

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 8,933 patients across 50 trials

Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia

Start: Nov 2024Est. completion: Jun 2029440 patients
Phase 4Recruiting
NCT03500211Oregon TherapeuticsLidoderm 5 % Topical Patch

Post-Op Lidocaine Patch

Start: Mar 2018Est. completion: Mar 201950 patients
Phase 4Completed
NCT03294109Angeles TherapeuticsAbdominal wall block with liposomal bupivicaine

Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy

Start: Jan 2018Est. completion: Jun 2020146 patients
Phase 4Completed

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

Start: Oct 2014Est. completion: Aug 201574 patients
Phase 4Completed
NCT02270437UNION therapeuticsropivacaine, fentanyl, adrenaline

Safety and Efficacy of Cocktail Periarticular Injection in Simultaneous Total Knee Arthroplasty

Start: Jun 2014Est. completion: Aug 201555 patients
Phase 4Completed
NCT01977937Oregon TherapeuticsGabapentin 250mg/5mL NDC:59762-5025-01

Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin

Start: Nov 2013Est. completion: Apr 201855 patients
Phase 4Completed

Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery

Start: Dec 2012Est. completion: Dec 2013206 patients
Phase 4Completed
NCT01344395Lundbeckropivacaine and ketorolac

Use of Local Infiltration Analgesia Following Total Hip Arthroplasty

Start: Mar 2010Est. completion: Sep 201180 patients
Phase 4Completed
NCT00927225Lundbeckropivacaine 0.2%, 50 mL

Local Infiltration Analgesia in Bilateral Knee Arthroplasty - Efficacy of Subcutaneous Wound Infiltration With Local Anesthetic

Start: Sep 2008Est. completion: Jun 200916 patients
Phase 4Completed
NCT00927888PfizerBupivacaine Block

Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery

Start: Aug 2007Est. completion: Aug 201056 patients
Phase 4Completed

A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction

Start: Mar 2004Est. completion: Aug 2004328 patients
Phase 4Completed
NCT05324358NeumentumKetorolac Tromethamine

Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

Start: Dec 2022Est. completion: May 2027341 patients
Phase 3Suspended
NCT05764525VivozonVVZ-149 Injections

Efficacy and Safety of VVZ-149 Injections in Patients Undergoing Laparoscopic Colectomy

Start: Jul 2021Est. completion: Nov 2022285 patients
Phase 3Completed
NCT04430088VivozonVVZ-149 Injections

Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

Start: Jun 2020Est. completion: Jan 2021300 patients
Phase 3Unknown
NCT03997838VivozonVVZ-149 Injections

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

Start: May 2019Est. completion: Aug 2019307 patients
Phase 3Completed

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

Start: Feb 2018Est. completion: May 2019194 patients
Phase 3Completed

Evaluation of Preoperative N1539 in Colorectal Surgery

Start: Oct 2017Est. completion: Sep 201857 patients
Phase 3Completed

Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery

Start: Mar 2017Est. completion: Aug 2018132 patients
Phase 3Completed

Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain

Start: Aug 2013Est. completion: Mar 2014562 patients
Phase 3Completed

Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery

Start: Jun 2008Est. completion: Aug 2011250 patients
Phase 3Completed

Surgical Pain After Inguinal Hernia Repair (SPAIHR)

Start: Jan 2008Est. completion: Sep 2009425 patients
Phase 3Completed

Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain

Start: Aug 2007Est. completion: Mar 2008148 patients
Phase 3Completed

Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy

Start: Jun 2007Est. completion: Oct 2010501 patients
Phase 3Completed

Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain

Start: Nov 2006Est. completion: Oct 2007135 patients
Phase 3Completed
NCT00150280Viatriscelecoxib and ibuprofen SR

Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery

Start: Oct 2004Est. completion: Jul 2005132 patients
Phase 3Completed

Anesthetic Premedication With a Cannabis Extract (Cannapremed)

Start: May 2015Est. completion: Dec 2024200 patients
Phase 2/3Unknown
NCT07412496Bausch HealthTopical Ocular BL1332 low dose

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

Start: Mar 2026Est. completion: Oct 2026130 patients
Phase 2Completed
NCT06204120Luye PharmaLPM3480392 Injection

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

Start: Nov 2022Est. completion: Jul 2023150 patients
Phase 2Completed
NCT03997812VivozonVVZ-149 Injections

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy

Start: May 2019Est. completion: Aug 201960 patients
Phase 2Completed
NCT03679013iNova PharmaceuticalsOral Gabapentin and Intravenous Acetaminophen

Effectiveness of an Opioid Sparing Pain Regimen in Cardiac Surgery

Start: Apr 2019Est. completion: Jul 201919 patients
Phase 2Completed
NCT03428230Sintetica30 mg Paracetamol 3%

Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures

Start: Aug 2018Est. completion: Oct 201960 patients
Phase 2Completed

Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores

Start: Feb 2018Est. completion: Oct 202180 patients
Phase 2Unknown

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

Start: Sep 2017Est. completion: Nov 202056 patients
Phase 2Completed
NCT00859313TalpheraSufentanil NanoTab PCA System/15 mcg

An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement

Start: Apr 2009Est. completion: Aug 200930 patients
Phase 2Completed

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain (MK-2295-005)

Start: Oct 2006Est. completion: May 200789 patients
Phase 2Completed

A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)

Start: Aug 2006Est. completion: Jan 200781 patients
Phase 2Terminated

MK0686 in Postsurgery Dental Pain (0686-002)

Start: Jul 2004Est. completion: Nov 2004114 patients
Phase 2Completed

Quadratus Lumborum Block for Total Hip Arthroplasty

Start: Mar 2022Est. completion: Jan 202780 patients
Phase 1Enrolling By Invitation

Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

Start: Mar 2021Est. completion: Mar 202285 patients
Phase 1Completed

Comparison of ESP Block and M-TAPA Block Efficiency in Postoperative Analgesia Management in Nephrectomy Cases

Start: Sep 2024Est. completion: Feb 2025
N/ANot Yet Recruiting
NCT06384664AtriCureAtricure's crysoSPHERE probe

Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy

Start: Jun 2024Est. completion: Apr 202880 patients
N/ARecruiting
NCT05017701MasimoBridge device

Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty

Start: Apr 2022Est. completion: May 20235 patients
N/ATerminated

Healing Touch After Cesarean

Start: Aug 2021Est. completion: Apr 2023210 patients
N/ACompleted
NCT04349397Oregon TherapeuticsMedication Tracking Form

Use of Analgesics and Pain Scores After Pediatric Adenotonsillectomy

Start: Aug 2019Est. completion: Jun 2021100 patients
N/AUnknown

Sitz Bath vs no Sitz Bath in Acute Anal Fissure Treatment

Start: Jan 2019Est. completion: Jan 202360 patients
N/AUnknown

pMDT in Thoracic Surgery--The Process Implementation Stage

Start: Dec 2018Est. completion: Aug 2021480 patients
N/ACompleted

pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage

Start: Sep 2018Est. completion: Aug 2021480 patients
N/ACompleted
NCT03290521Biocorpintraperitoneal washing with saline solution

Intraperitoneal Lavage for Reducing Pain in Laparoscopy

Start: Jul 2018Est. completion: Dec 2020277 patients
N/ACompleted
NCT03565705EppendorfOpen abdominal prostatectomy

Spinal Anesthesia and Peri-operative Opioid Consumption in Open Abdominal Prostatectomy

Start: Apr 2018Est. completion: Oct 2018636 patients
N/ACompleted
NCT03380949EppendorfOpioid administration

Monitor-Guided Analgesia During General Anesthesia - Part II

Start: Dec 2017Est. completion: Jun 201896 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

16 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 8,933 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.